TABLE 1.
Black–White Disparities in Mortality Associated With HIV, Breast Cancer, and Respiratory Distress Syndrome: United States, 1979–2005
| Age Group and Perioda | Mortality Rate Ratio (95% CI) | Risk Difference (95% CI) |
| HIV among men | ||
| 25–34 y | ||
| 1987–1991 | 2.98 (2.91, 3.05) | 4.90 (4.75, 5.05) |
| 1993–1995 | 3.40 (3.32, 3.49) | 8.73 (8.48, 8.98) |
| 1997–2005 | 6.28 (6.08, 6.49) | 25.11 (21.47, 25.82) |
| 35–44 y | ||
| 1987–1991 | 3.21 (3.14, 3.29) | 7.80 (7.58, 8.02) |
| 1993–1995 | 3.94 (3.87, 4.02) | 16.53 (16.18, 16.89) |
| 1997–2005 | 6.20 (6.07, 6.32) | 6.24 (6.13, 6.35) |
| 45–54 y | ||
| 1987–1991 | 2.84 (2.73, 2.95) | 3.97 (3.77, 4.18) |
| 1993–1995 | 4.51 (4.38, 4.61) | 11.90 (11.52, 12.27) |
| 1997–2005 | 8.36 (8.17, 8.56) | 70.43 (69.13, 71.73) |
| 55–64 y | ||
| 1987–1991 | 3.17 (2.97, 3.38) | 18.81 (17.24, 20.38) |
| 1993–1995 | 5.05 (4.78, 5.34) | 5.49 (5.18, 5.80) |
| 1997–2005 | 11.08 (10.65, 11.52) | 47.88 (46.48, 49.29) |
| 65–74 y | ||
| 1987–1991 | 3.49 (3.06, 3.97) | 6.74 (5.64, 7.84) |
| 1994–1995 | 7.36 (6.49, 8.35) | 26.12 (23.13, 29.11) |
| 1997–2005 | 12.29 (11.41, 13.25) | 21.72 (20.51, 22.93) |
| HIV among women | ||
| 25–34 y | ||
| 1987–1991 | 8.85 (8.35, 9.39) | 16.70 (15.90, 17.42) |
| 1993–1995 | 8.13 (7.18, 8.55) | 34.71 (33.39, 36.04) |
| 1997–2005 | 14.02 (13.28, 14.81) | 16.53 (16.02, 17.05) |
| 35–44 y | ||
| 1987–1991 | 11.21 (10.50, 11.97) | 19.15 (18.29, 20.01) |
| 1993–1995 | 9.94 (9.49, 10.41) | 50.72 (49.07, 52.37) |
| 1997–2005 | 13.25 (12.76, 13.76) | 29.76 (29.09, 30.44) |
| 45–54 y | ||
| 1987–1991 | 9.28 (8.23, 10.45) | 76.13 (69.23, 83.04) |
| 1993–1995 | 10.76 (9.95, 11.64) | 26.67 (25.17, 28.16) |
| 1997–2005 | 15.69 (14.95, 16.46) | 23.87 (23.19, 24.55) |
| 55–64 y | ||
| 1987–1991 | 6.42 (5.39, 7.65) | 32.38 (27.15, 37.41) |
| 1993–1995 | 10.81 (9.40, 12.44) | 11.72 (10.53, 12.91) |
| 1997–2005 | 15.18 (13.90, 16.57) | 104.60 (98.86, 110.40) |
| Breast cancer | ||
| 45–54 y | ||
| 1984–1990 | 1.34 (1.31, 1.39) | 1.55 (1.39, 1.72) |
| 1992–1998 | 1.54 (1.50, 1.58) | 2.05 (1.91, 2.19) |
| 1999–2005 | 1.72 (1.69, 1.77) | 2.10 (2.00, 2.21) |
| 55–64 y | ||
| 1984–1990 | 1.10 (1.07, 1.12) | 0.81 (0.59, 1.03) |
| 1992–1998 | 1.29 (1.26, 1.13) | 1.92 (1.72, 2.19) |
| 1999–2005 | 1.45 (1.41, 1.48) | 2.47 (2.29, 2.65) |
| 65–74 | ||
| 1985–1990 | 0.81 (0.79, 0.83) | −0.25 (−0.28, −0.22) |
| 1992–1998 | 1.12 (1.09, 1.15) | 0.12 (0.09, 0.15) |
| 1999–2005 | 1.19 (1.06, 1.13) | 1.58 (1.34, 1.83) |
| 75–84 y | ||
| 1985–1990 | 0.90 (0.88, 0.93) | −0.14 (−0.17, −0.11) |
| 1992–1998 | 1.05 (1.02, 1.07) | 0.06 (0.02, 0.10) |
| 1999–2005 | 1.10 (1.07, 1.13) | 0.12 (0.09, 0.16) |
| ≥85 y | ||
| 1984–1990 | 0.94 (0.89, 0.99) | −0.11 (−0.20, −0.03) |
| 1992–1998 | 1.00 (0.96, 1.04) | −0.00 (−0.08, 0.08) |
| 1999–2005 | 1.10 (1.07, 1.14) | 0.19 (−0.12, 0.27) |
| Newborn respiratory distress syndrome (infancy) | ||
| 1979–1987 | 1.80 (1.76, 1.85) | 7.97 (7.59, 8.31) |
| 1988–1989 | 2.24 (2.13, 2.34) | 8.93 (8.21, 9.65) |
| 1990–1998 | 2.72 (2.64, 2.81) | 6.23 (5.96, 6.49) |
| 1999–2005a | 2.79 (2.65, 2.93) | 3.00 (2.80, 3.19) |
Note. CI = confidence interval.
a
For HIV, time periods were preinnovation, near innovation, and postinnovation, respectively. Two postinnovation periods, 1992–1998 and 1999–2005, are noted for breast cancer, and 2 postintervention periods, 1990–1998 and 1999–2005 are noted for respiratory distress syndrome.